Title |
Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer
|
---|---|
Published in |
BMC Cancer, December 2014
|
DOI | 10.1186/1471-2407-14-977 |
Pubmed ID | |
Authors |
Prabhakar Rajan, Jacqueline Stockley, Ian M Sudbery, Janis T Fleming, Ann Hedley, Gabriela Kalna, David Sims, Chris P Ponting, Andreas Heger, Craig N Robson, Rhona M McMenemin, Ian D Pedley, Hing Y Leung |
Abstract |
Although chemotherapy for prostate cancer (PCa) can improve patient survival, some tumours are chemo-resistant. Tumour molecular profiles may help identify the mechanisms of drug action and identify potential prognostic biomarkers. We performed in vivo transcriptome profiling of pre- and post-treatment prostatic biopsies from patients with advanced hormone-naive prostate cancer treated with docetaxel chemotherapy and androgen deprivation therapy (ADT) with an aim to identify the mechanisms of drug action and identify prognostic biomarkers. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Spain | 1 | 1% |
Unknown | 74 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 17 | 22% |
Researcher | 12 | 16% |
Student > Bachelor | 9 | 12% |
Other | 8 | 11% |
Student > Master | 8 | 11% |
Other | 7 | 9% |
Unknown | 15 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 24% |
Biochemistry, Genetics and Molecular Biology | 14 | 18% |
Agricultural and Biological Sciences | 11 | 14% |
Engineering | 4 | 5% |
Computer Science | 2 | 3% |
Other | 7 | 9% |
Unknown | 20 | 26% |